Search

Your search keyword '"Fabrellas, Núria"' showing total 324 results

Search Constraints

Start Over You searched for: Author "Fabrellas, Núria" Remove constraint Author: "Fabrellas, Núria"
324 results on '"Fabrellas, Núria"'

Search Results

2. Liver fibrosis screening increases alcohol abstinence

3. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis

4. Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular Profiling

5. Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

6. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

8. Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

10. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

11. LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

12. OS-059 Unveiling Socioeconomic Disparities on Liver Disease: A Comparative Study of ALD, MASLD, and MetALD Patients

13. TOP-241-YI Longitudinal changes in liver stiffness measurements in a population-based screening cohort of 5, 517 participants

14. THU-056 Soluble PD-L1 levels as predictors of ACLF in decompensated cirrhosis: findings from two independent cohorts

16. WED-055 Effect of long-term treatment with Simvastatin and Rifaximin in mitochondrial and proinflammatory pathways in patients with decompensated cirrhosis. A single-cell RNA seq analysis in PBMCs

17. Liver cirrhosis

20. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis

21. Nurses, midwives and students' reports of effective dedicated education units in five European countries: A qualitative study.

22. Older Adults With Complex Chronic Conditions Who Receive Care at Home: The Importance of Primary Care Assessment

25. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia

26. Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals

27. Telerehabilitation following fast-track total knee arthroplasty is effective and safe: a randomized controlled trial with the ReHub® platform.

29. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial

30. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study

31. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

32. Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure

35. Patients with alcohol-related cirrhosis who recompensate on follow-up have a characteristic metabolomic profile with differential concentrations of lipid and amino-acid metabolites

36. Health-related quality of life in a population at-risk of NAFLD or ArLD

37. Refractory ascites in cirrhosis is associated with a major psychological burden in patients with cirrhosis and caregivers

38. Patients with risk factors for liver diseases associated with hepatic steatosis constitute the target population for liver fibrosis assessment in primary care

39. Simvastatin plus Rifaximin to prevent ACLF in patients with decompensated cirrhosis. A randomised, double-blind, placebo-controlled, phase-3 trial: the liverhope efficacy trial

40. Changes in frailty as a predictor of readmission risk in patients with liver cirrhosis. Preliminary results

41. Serum PDL1 levels are associated with increased risk of bacterial infections in non-hospitalised patients with cirrhosis

42. Construction of nursing knowledge in commodified contexts: Views and experiences of nurses regarding primary care.

46. Natural history of hepatic steatosis associated to metabolic syndrome. Longitudinal study with 5 years of follow-up.

47. Prospective evaluation of the EASL clinical guidelines algorithm of management of acute kidney injury in cirrhosis

48. Quality of life in patients with advanced cirrhosis. Relationship with the development of complications

49. Blood metabolomics unveils mitochondrial dysfunction as a potential key feature in the pathogenesis of hepatorenal syndrome

50. PD-1/PD-L1 pathway is related to infection development and early mortality in patients with cirrhosis

Catalog

Books, media, physical & digital resources